Regenerex Pharma (RGPX) Capital Expenditures (2017 - 2023)

Regenerex Pharma (RGPX) reported Capital Expenditures of $2670.0 for Q3 2023, down 26.43% quarter-over-quarter from $3629.0 in Q2 2023.

Regenerex Pharma (RGPX) Capital Expenditures (2017 - 2023) Analysis & Trends

Regenerex Pharma (RGPX) has 3 years of Capital Expenditures data on file, last reported at $2670.0 in Q3 2023.

Capital Expenditures for Q3 2023 came in at $2670.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2024 was $6299.0 (up 109.97% YoY), and the FY2025 annual result was $1228.0, down 80.5% from the prior year.
Capital Expenditures retreated to $2670.0 in Q3 2023 per RGPX's latest filing, from $3629.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $3629.0 in Q2 2023 and troughed at $2670.0 in Q3 2023.

Download Data